Showing 8,306 results

Filters Content type: News, Editors' picks Country: Sub-Saharan Africa
PrEP science

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

News
17 March 2025
The search for an HIV prevention vaccine

US funding cuts imperil search for HIV vaccine

Editor's pick
Spotlight
17 March 2025
Retention & linkage to care

Positive interactions with healthcare workers improve HIV care retention in Malawi and Zambia

News
17 March 2025
Global health initiatives

Kenya HIV Patients Live in Fear as US Aid Freeze Strands Drugs in Warehouse

Editor's pick
Medscape (requires free registration)
17 March 2025
Adherence

Urine testing plus feedback can increase PrEP adherence in pregnant women

Editor's pick
Healio
17 March 2025
Finance & funding

Cuts to USAID-funded research another blow to global HIV response

Editor's pick
Devex (requires free registration)
17 March 2025
Finance & funding

How much does South Africa's HIV response depend on US funding?

Editor's pick
Spotlight
17 March 2025
Government, leadership & policy

South Africa: Turn PEPFAR funding freeze crisis into opportunity

Editor's pick
University of Cape Town News
17 March 2025
Retention & linkage to care

PEPFAR study shows the deadly impact of stopping children’s HIV treatment

News
12 March 2025
Antibody-based treatment

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

News
12 March 2025
Cancer

Uganda achieves rapid scale-up of cervical screening for women living with HIV

News
9 July 2024
Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

News
8 July 2024
Finance & funding

What a PEPFAR funding cut could mean for the HIV response in Botswana

Editor's pick
Devex (requires free registration)
5 July 2024
Adherence

Most people on dolutegravir resuppress viral load after a detectable result

News
5 July 2024
Retention & linkage to care

Retention in HIV care has declined since 'Treat All' guidelines introduced

News
28 June 2024
Young people

New study reveals effective strategy to improve HIV prevention in South Africa

Editor's pick
Africa Health Research Institute
26 June 2024
Injectable & long-acting PrEP

Statement From The Gilead’s Purpose 1 Global Community Accountability Board, The African Women’s Prevention Community Accountability Board, Our Partners And Community Partners

Editor's pick
African Women’s Prevention Community Accountability Board
24 June 2024
Injectable & long-acting PrEP

ICWEA Statement on Gilead’s announcement of twice-yearly Lenacapavir (LEN) for HIV prevention.

Editor's pick
International Community of Women living with HIV Eastern Africa
21 June 2024
Human rights

UNAIDS applauds Namibian Constitutional Court's decision to declare unconstitutional the law that had criminalised same-sex relationships

Editor's pick
UNAIDS
21 June 2024
Injectable & long-acting PrEP

Landmark Trial in South Africa and Uganda Finds Twice Yearly HIV Prevention Injection Safe and Highly Effective

Editor's pick
AVAC
20 June 2024
Injectable & long-acting PrEP

Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention

Editor's pick
Gilead Sciences press release
20 June 2024
Mpox (monkeypox)

South Africa Waits for Mpox Vaccines After Confirming Seven ‘Severe Cases’

Editor's pick
Health Policy Watch
20 June 2024
HIV prevention policy

HIV prevention drug uptake is slow. Can offering choices change that?

Editor's pick
Devex (requires free registration)
20 June 2024
HIV testing programmes & uptake

In South Africa, traditional healers join the fight against HIV

Editor's pick
Associated Press
19 June 2024